Toronto, Ontario--(Newsfile Corp. - December 11, 2017) - Gunpowder Capital Corp., (CSE: GPC) (CSE: GPC.PR.A) (OTCQB: GNPWF) (FSE: YS6N) ("Gunpowder" or the "Corporation") announced today that it continues to work with its client Eastgate Biotech Corp., (OTC Pink: ETBI) ("Eastgate").
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.